Auxly Cannabis Group (3KF0) Q3 2026 Earnings Report

The call was strongly positive, supported by quarterly records in revenue, adjusted EBITDA and cash flow, stable 56% gross margins, strong cash conversion, brand and product leadership, planned capacity expansion and a favorable Canadian market outlook. The main challenges were lower B2B volumes and prices, structural margin pressure in vapes, potential future distillate cost increases, evolving international regulations and incomplete national excise-stamp harmonization. Highlights significantly outweighed the lowlights.

Auxly expects to continue to grow net revenue above market rates through product innovation, continued investment in distribution and increased capacity at Auxly Leamington, with total capital expenditures of up to $30 million through the end of 2028 expected to increase production capacity by 30% from 2025 levels; it expects to commit between $10 million and $12 million of cash flow from operations to these projects in 2026, with a portion of the associated expenditures expected to occur in the first half of 2027. The company expects to maintain profitability and generate strong cash flow, target SG&A growth at the same rate as revenue growth, maintain its category gross margins within its margin envelope, and expects Q4 to be a strong quarter; it believes the Canadian market grows 5% a year between here and 2030, reaching a $6 billion or $7 billion market, and that it can grow faster than that 5% rate of market growth.